Sparrow Pharmaceuticals
Portland, OR
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
sparrowpharma.comCompany Details
Founded
- 2013
Employees
- Between 5 - 10 employees
Raised
- $61,275,256
Headquarters Location
- Portland, OR
Public
- No
Acquired
- No
CEO
Robert Jacks
Founders
- David A. Katz
Company Collections
These are collections Sparrow Pharmaceuticals is a part of. Click on the collection name to view similar companies.